Gill, J. L.Albanell, J.Avouac, B.Dank, M.Duncombe, R.Fink-Wagner, A.Hutton, J.Jahnz-Rozyk, K.Kössler, I.Podrazilova, K.Schramm, W.Spandonaro, F.Carneiro, António VazWartenberg, M.Kanavos, P.2019-11-262019-11-262017Value in Health 20(2017) A399–A8111098-3015http://hdl.handle.net/10451/40277Copyright © 2017 Published by Elsevier Inc.Objectives: Interest in Real World Evidence (RWE), data not collected via traditional randomised controlled trials (RCT) used in different contexts, is increasing for market-access and reimbursement decision-makers. A global survey was undertaken to understand the use of RWE in these contexts.engjournal article10.1016/j.jval.2017.08.15541524-4733